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Optic neuritis in a patient with celiac disease
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Brian MRICeliac disease is deﬁned as permanent gluten intolerance.
Proximal small intestine mucosa chronic inﬂammation which
is healed by a gluten-free diet is one of the most signiﬁcant
characteristics of this disease; however, it can be reintroduced
if gluten is returned to diet [1]. Presumably, neurologic pre-
sentations may be the prime manifestation of celiac disease.
Cerebellar ataxia, epilepsy, peripheral neuropathy, autism,
depression, and headache, especially in unknown cases, might
be the neurologic presentations of celiac disease. The neuro-
ophthalmic involvement as a manifestation of celiac disease is
extremely rare [2]. This letter studies a patient with celiac
disease presented with ophthalmoparesis.
The patient was a 43-year-old female who was referred to
our center by an ophthalmologist because of right-sided optic
neuritis. The other neurologist examinations were unremark-
able. Brain magnetic resonance imaging (MRI) showed
nonspeciﬁc white matter lesions (Fig. 1-A). Cervical and orbital
MRI did not show any signiﬁcant results. Vasculitis tests were
normal and anti-aquaporin 4 antibody was negative too.
Lumbar puncture was done for the patient. The cerebrospinal
ﬂuid (CSF) analysis was normal. The oligoclonal band (OCB)
was negative. The optic neuritis was improved by intravenous
(IV) methylprednisolon pulse therapy 1 g for 5 days. The drug
and familial history of patient were unremarkable. The patient
had a history of a right-side third nerve palsy 11 years ago
which was recovered with 5 days IV methylprednisolon pulse
therapy. The brain MRI of that time had revealed some non-
speciﬁc bright white matter lesions. Three years ago, she had
complained of recurrent urticaria. Laboratory examination
indicated recurrent elevated erythrocyte sedimentation rate
(ESR). IgG Anti Endomesial antibody (EMA) test and Tissue
Transglutaminase (TTG) antibody were elevated too. Uppergastrointestinal endoscopy showed moderate corporal gas-
tritis and moderate duodenitis. Duodenal mucosal biopsy
demonstrated signiﬁcant lymphocytic proliferation, crypt
hyperplasia, and villi atrophy compatible with type III
modiﬁed Marsh classiﬁcation of celiac disease (Fig. 1-B and C).
Gluten restriction regime was prescribed for her. As a result, the
urticaria improved.
According to the patient's past medical history, the
neurologic complication of celiac disease was considered. In
addition, the MRI and OCB did not support the diagnosis of
multiple sclerosis (MS) (Fig. 1-D). Therefore, no special drug
was prescribed and it was decided to have close monitoring on
her case.
The prevalence of celiac disease in general population is
relatively high [1]. EMA and TTG antibody are useful as they
are celiac disease's initial screen tests. Characteristic
histologic changes were classiﬁed by Marsh and initially
put forward by him, although they were modiﬁed later [1].
22% of patients with celiac disease presented neurologic and
pschyciateric manifestations [3]. Seizure, ataxia, cerebellar
degeneration, neuropathy, myopathy, depression, anxiety,
schizophrenia, autism, migraine headache, multiple sclero-
sis, myasthenia gravis, attention deﬁcit hyperactive dis-
orders and nonspeciﬁc white matter lesions were reported in
patients with celiac disease [2,3]. Neuro-ophthalmic in-
volvement of celiac disease is extremely rare and restricted
to pseudotumor cerebri, uveistis, orbital myositis, retinopa-
thy, and cataract [4].
Anti-aquaporin 4 antibody positive optic neuritis, associat-
ed with celiac disease, was reported but the patient had a past
history of recurrent episodic abdominal pain and psoriasis,
and optic neuritis was not the ﬁrst manifestation [5]. Anti-
aquaporin 4 antibody in our patient was negative. Another
probable diagnosis for our patient is MS. According to atypical
brain imaging of the patient, lumbar puncture was done and
OCB was reported to be negative. Thus, MS was not considered
as a probable diagnosis in this patient.
To the best of the authors' knowledge, this case is the ﬁrst
celiac disease presenting neuro-ophthalmologic symptoms
as a prim manifestation and optic neuritis in the course of
disease.
The authors suggest that celiac disease is supposed to be
considered in atypical neuro-ophthalmological presenta-
Fig. 1 – (A) Brain MRI showed nonspecific white matter lesions. (B and C) Duodenal mucosal biopsy demonstrated significant
lymphocytic proliferation, crypt hyperplasia, and villi atroph. (D) The brain MRI which had been done 11 years ago had
revealed some non specific bright white matter lesions.
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vague clinical and laboratory ﬁndings favored on a systemic
autoimmune problem.
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